Yu-Hong Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yu-Hong Cheng has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
An-Ming Xie
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China
1 shared publicationChaoyan Zhang
Department of Ophthalmology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China
1 shared publicationCheng Pei
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China
1 shared publicationHua Wang
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China
1 shared publication- Jingbo Hu
Department of Ophthalmology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China
1 shared publication Li-Lun Wang
Department of Ophthalmology, Affiliated Hospital of Yan'an University, Yan'an 716000, Shaanxi Province, China
1 shared publication
Latest Publications
- Open Access
- 11 September 2026
- Published by Springer Nature in BMC Ophthalmology
Comparison of perfluorocarbon liquid-assisted versus conventional internal limiting membrane peeling in highly myopic macular hole retinal detachment: a retrospective study
Background: Macular hole retinal detachment (MHRD) in highly myopic eyes represents a severe, vision-threatening entity within the spectrum of myopic traction maculopathy (MTM) and remains among the most surgically challenging vitreoretinal conditions, primarily owing to the characteristic pathoanatomical alterations inherent to high myopia, including excessive axial elongation, posterior staphyloma, and progressive chorioretinal thinning. Purpose: The primary purpose of this study was to compare postoperative restoration of ellipsoid zone (EZ) continuity between PFCL-assisted and conventional ILM inverted flap techniques for the surgical repair of high myopic MHRD, assessed on spectral-domain optical coherence tomography (SD-OCT). Secondary objectives were to compare additional anatomical outcomes (macular hole closure rate; closure morphology [U-type, V-type, W-type]; and external limiting membrane (ELM) restoration), functional outcomes (best-corrected visual acuity (BCVA) improvement), and the incidence of postoperative complications between the two groups. Methods: This single-center, retrospective, non-randomized comparative case series comprised 37 highly myopic eyes (axial length ≥ 26 mm) with full-thickness MHRD that underwent primary 25-gauge pars plana vitrectomy combined with the inverted ILM flap technique between April 2022 and October 2025. Eyes were categorized into two groups based on the surgical approach employed for ILM flap manipulation: the PFCL-assisted group ( n = 20), in which perfluorocarbon liquid was utilized to stabilize the inverted ILM flap, and the conventional group ( n = 17), in which the ILM flap was positioned under balanced salt solution infusion. All patients were followed up for a minimum of 6 months, with standardized assessments performed at 3 and 6 months postoperatively. Results: Baseline characteristics were comparable between the two groups. Regarding anatomical and microstructural outcomes, EZ restoration at 6 months was better in the PFCL-assisted group (70.0% vs. 29.4%, P = .02), whereas ELM restoration demonstrated no statistical significance (35.0% vs. 11.8%, P = .14). The macular hole closure rate did not reach statistical significance (85.0% vs. 70.59%, P = .43). Regarding functional outcomes, postoperative BCVA did not differ significantly between groups at either 3 months ( P = .69) or 6 months ( P = .81). However, postoperative BCVA was significantly correlated with preoperative BCVA at both 3 months ( r = .53, P = .03) and 6 months ( r = .51, P = .04). In binary logistic regression adjusted for axial length and preoperative maximum macular hole diameter, the odds of EZ continuity at 6 months were lower in the conventional group than in the PFCL-assisted group (OR = 0.02, 95% CI: 0.001 to 0.47, P = .02), and baseline logMAR BCVA (B = -0.45; 95% CI, -0.80 to -0.09, P = .02) was an independent predictor of 6-month BCVA improvement. Conclusions: In highly myopic MHRD, a higher rate of EZ continuity at 6 months was observed after PFCL-assisted ILM inverted flap surgery than after conventional surgery. However, this anatomical benefit did not translate into significantly better short-term visual outcomes. All analyses were exploratory, and these findings are hypothesis-generating and require confirmation in larger prospective studies with longer follow-up.
- 11 September 2026
- Published by Springer Nature in BMC Ophthalmology
Open AccessComparison of perfluorocarbon liquid-assisted versus conventional internal limiting membrane peeling in highly myopic macular hole retinal detachment: a retrospective study
Background: Macular hole retinal detachment (MHRD) in highly myopic eyes represents a severe, vision-threatening entity within the spectrum of myopic traction maculopathy (MTM) and remains among the most surgically challenging vitreoretinal conditions, primarily owing to the characteristic pathoanatomical alterations inherent to high myopia, including excessive axial elongation, posterior staphyloma, and progressive chorioretinal thinning. Purpose: The primary purpose of this study was to compare postoperative restoration of ellipsoid zone (EZ) continuity between PFCL-assisted and conventional ILM inverted flap techniques for the surgical repair of high myopic MHRD, assessed on spectral-domain optical coherence tomography (SD-OCT). Secondary objectives were to compare additional anatomical outcomes (macular hole closure rate; closure morphology [U-type, V-type, W-type]; and external limiting membrane (ELM) restoration), functional outcomes (best-corrected visual acuity (BCVA) improvement), and the incidence of postoperative complications between the two groups. Methods: This single-center, retrospective, non-randomized comparative case series comprised 37 highly myopic eyes (axial length ≥ 26 mm) with full-thickness MHRD that underwent primary 25-gauge pars plana vitrectomy combined with the inverted ILM flap technique between April 2022 and October 2025. Eyes were categorized into two groups based on the surgical approach employed for ILM flap manipulation: the PFCL-assisted group ( n = 20), in which perfluorocarbon liquid was utilized to stabilize the inverted ILM flap, and the conventional group ( n = 17), in which the ILM flap was positioned under balanced salt solution infusion. All patients were followed up for a minimum of 6 months, with standardized assessments performed at 3 and 6 months postoperatively. Results: Baseline characteristics were comparable between the two groups. Regarding anatomical and microstructural outcomes, EZ restoration at 6 months was better in the PFCL-assisted group (70.0% vs. 29.4%, P = .02), whereas ELM restoration demonstrated no statistical significance (35.0% vs. 11.8%, P = .14). The macular hole closure rate did not reach statistical significance (85.0% vs. 70.59%, P = .43). Regarding functional outcomes, postoperative BCVA did not differ significantly between groups at either 3 months ( P = .69) or 6 months ( P = .81). However, postoperative BCVA was significantly correlated with preoperative BCVA at both 3 months ( r = .53, P = .03) and 6 months ( r = .51, P = .04). In binary logistic regression adjusted for axial length and preoperative maximum macular hole diameter, the odds of EZ continuity at 6 months were lower in the conventional group than in the PFCL-assisted group (OR = 0.02, 95% CI: 0.001 to 0.47, P = .02), and baseline logMAR BCVA (B = -0.45; 95% CI, -0.80 to -0.09, P = .02) was an independent predictor of 6-month BCVA improvement. Conclusions: In highly myopic MHRD, a higher rate of EZ continuity at 6 months was observed after PFCL-assisted ILM inverted flap surgery than after conventional surgery. However, this anatomical benefit did not translate into significantly better short-term visual outcomes. All analyses were exploratory, and these findings are hypothesis-generating and require confirmation in larger prospective studies with longer follow-up.
- 18 November 2020
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 13 (11) , 1773-1779
Parafoveal retinal massage combined with autologous blood cover in the management of giant, persistent or recurrent macular holes
To assess the efficacy and safety of parafoveal retinal massage combined with autologous whole blood cover in the treatment of refractory macular holes (MHs) and present the surgical procedure. Patients with giant (minimum diameter ≥800 µm), recurrent or persistent MHs who underwent PPV combined with parafoveal retinal massage and autologous whole blood cover using C3F8 as tamponade agent from February 2018 to May 2019 were enrolled in this retrospective study. After surgery, all patients were informed to maintain a prone position for at least 7d. Preoperative and postoperative best-corrected visual acuities (BCVAs) were compared and MH closure rate was measured as the main outcome. A total of 13 MH patients consisted of 6 giant MHs, 4 persistent holes and 3 recurrent holes (5 men and 8 women; average age was 56.40±11.72y) were enrolled in this study. MH closure was achieved in 11 eyes by this modified surgical technique while 2 eyes failed. Revitrectomy with autologous neurosensory retinal patch transplantations was applied for those 2 patients and then both holes were closed. No intraoperative complications were observed. BCVA improved from 1.73 logMAR to 0.74 logMAR at 6mo postoperation. There was significant difference in BCVA before versus after the surgery (P<0.05). There were no adverse events occurred during the follow-up period. With easier surgical procedure, parafoveal retinal massage combined with autologous whole blood cover is an effective addition to the surgical options for the management of refractory MHs.
- 18 November 2020
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 13 (11) , 1773-1779
Parafoveal retinal massage combined with autologous blood cover in the management of giant, persistent or recurrent macular holes
To assess the efficacy and safety of parafoveal retinal massage combined with autologous whole blood cover in the treatment of refractory macular holes (MHs) and present the surgical procedure. Patients with giant (minimum diameter ≥800 µm), recurrent or persistent MHs who underwent PPV combined with parafoveal retinal massage and autologous whole blood cover using C3F8 as tamponade agent from February 2018 to May 2019 were enrolled in this retrospective study. After surgery, all patients were informed to maintain a prone position for at least 7d. Preoperative and postoperative best-corrected visual acuities (BCVAs) were compared and MH closure rate was measured as the main outcome. A total of 13 MH patients consisted of 6 giant MHs, 4 persistent holes and 3 recurrent holes (5 men and 8 women; average age was 56.40±11.72y) were enrolled in this study. MH closure was achieved in 11 eyes by this modified surgical technique while 2 eyes failed. Revitrectomy with autologous neurosensory retinal patch transplantations was applied for those 2 patients and then both holes were closed. No intraoperative complications were observed. BCVA improved from 1.73 logMAR to 0.74 logMAR at 6mo postoperation. There was significant difference in BCVA before versus after the surgery (P<0.05). There were no adverse events occurred during the follow-up period. With easier surgical procedure, parafoveal retinal massage combined with autologous whole blood cover is an effective addition to the surgical options for the management of refractory MHs.
- Open Access
- 18 January 2017
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 10 (1) , 30-34
Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression
To investigate the effect of high mobility group protein box-1 (HMGB1) siRNA on proliferation and apoptosis of retinoblastoma (Rb) cells. The expression of HMGB1 in Rb cells were detected by real-time polymerase chain reaction (RT-PCR) and Western blot. Chemically synthesized HMGB1 siRNA was transfected into Y79 cells. The inhibitory rate was also examined by RT-PCR and Western blot. After HMGB1 siRNA transfection, the cell proliferation was analyzed by MTT, and cell apoptosis was detected by Caspase-3 active detection kit. Cell cycle distribution and apoptosis were detected by flow cytometry. The expression of HMGB1 significantly elevated in Rb cells (P<0.01). After transfected by siRNA, the HMGB1 protein level of Y79 cells was significantly reduced (P<0.01). After siRNA interference HMGB1, the proportion of proliferating cells reduced, and the proportion of quiescent cells increased (P<0.05). In addition, apoptosis rate of Y79 cells increased from 2.03% to 9.10% after interfering with HMGB1 siRNA (P<0.05). Specific HMGB1 siRNA can inhibit the expression of HMGB1. The effect may be attributed to inhibit the proliferation and promote cell apoptosis.
- 18 January 2017
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 10 (1) , 30-34
Open AccessEffect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression
To investigate the effect of high mobility group protein box-1 (HMGB1) siRNA on proliferation and apoptosis of retinoblastoma (Rb) cells. The expression of HMGB1 in Rb cells were detected by real-time polymerase chain reaction (RT-PCR) and Western blot. Chemically synthesized HMGB1 siRNA was transfected into Y79 cells. The inhibitory rate was also examined by RT-PCR and Western blot. After HMGB1 siRNA transfection, the cell proliferation was analyzed by MTT, and cell apoptosis was detected by Caspase-3 active detection kit. Cell cycle distribution and apoptosis were detected by flow cytometry. The expression of HMGB1 significantly elevated in Rb cells (P<0.01). After transfected by siRNA, the HMGB1 protein level of Y79 cells was significantly reduced (P<0.01). After siRNA interference HMGB1, the proportion of proliferating cells reduced, and the proportion of quiescent cells increased (P<0.05). In addition, apoptosis rate of Y79 cells increased from 2.03% to 9.10% after interfering with HMGB1 siRNA (P<0.05). Specific HMGB1 siRNA can inhibit the expression of HMGB1. The effect may be attributed to inhibit the proliferation and promote cell apoptosis.